The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFST.L Regulatory News (FST)

  • There is currently no data for FST

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to announcement by Frontier

7 Aug 2019 11:20

RNS Number : 2621I
Science Group PLC
07 August 2019
 

 

7 August 2019

Science Group plc

(the "Company")

Response to announcement by Frontier Smart Technologies Group Limited

("Frontier")

 

 

Science Group plc (AIM:SAG) notes the announcement and trading update issued by Frontier (AIM:FST) today.

 

On 29 July 2019, following months of trying to get the Frontier Board to engage with Science Group, an EGM requisition was sent to Frontier. (Contrary to the implication in the Frontier announcement today, the Frontier Board has been aware of the EGM requisition for nine days.) As a result, the Frontier Board finally agreed to engage and, on 30 July 2019, Frontier and Science Group announced the proposed changes to the Frontier Board "subject to completion of standard pre-appointment diligence checks by N+1 Singer as Nomad to Frontier and completion of Science Group due diligence." Following a request from Frontier's Adviser, Science Group confirmed that subject to satisfactory progress, the EGM notice would be withdrawn at the appropriate time.

 

Since that time, Frontier has provided information to Science Group which has been reviewed. The implications of the analysis by Science Group of that information have been provided to Frontier and its Advisers on a timely basis. The analysis and discussions have been intensive including meetings with operating management on Monday and Tuesday of this week. In Science Group's opinion, the strategy of Frontier needs to be significantly revised from that which has demonstrably failed over the past 18 months but Science Group remains excited by the Frontier business, its employees and the potential opportunities for collaboration.

 

Science Group highlight the Frontier clarification today regarding bank covenants and credit facility. This became apparent to Science Group during the due diligence activities and was raised to Frontier in a timely manner. As a result, Martyn Ratcliffe and Sarah Cole (the proposed Directors) advised Frontier that they considered it would be imprudent to accept the role of Director on the Frontier Board unless or until certain strategic and financial matters were addressed, in advance of their appointments. Frontier and its Advisers were first notified on Wednesday 31 July 2019 of this situation.

 

Science Group has requested to speak directly to Clydesdale Bank but to date this has not been possible. In Science Group's opinion, Frontier would benefit significantly from a refinancing to eliminate the bank covenant risk and provide the financial stability that Frontier requires. Science Group has provided an outline structure of a possible refinancing to Frontier. However, despite the seriousness of the situation, the Frontier Board has not engaged with Science Group on this matter in any meaningful way.

 

Frontier shareholders should recall that throughout the Offer period, including on 15 July, the Frontier Board maintained its position that it "strongly recommends that Shareholders neither accept the Science Group Offer on its current terms, per the offer document distributed to shareholders on 2 July 2019, nor sell any Frontier shares via the Panmure Gordon dealing facility." The Offer and the Panmure Gordon Trading Facility were closed on 19 July 2019.  

 

Science Group holds the equivalent of 47.6% of Frontier voting shares.

 

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina

(Corporate Finance)

Erik Anderson (Corporate Broking)

 

 

 

Tel: +44 (0) 20 7886 2500

MHP Communications (PR Adviser to Science Group)

Reg Hoare / Pete Lambie

 

Tel: +44 (0) 20 3128 8100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPLLFLITRIDIIA
Date   Source Headline
20th Feb 201210:16 amRNSHolding(s) in Company
16th Feb 20127:00 amRNSCompletion of placing
13th Feb 20127:00 amRNSTrading update
13th Feb 20127:00 amRNSPlacing raises £11.2m
3rd Jan 20127:00 amRNSSubsidiary established with Imagination Technologi
24th Oct 20117:00 amRNSTelran distribution clearance
21st Sep 20117:00 amRNSHalf year results
9th Aug 20114:52 pmRNSNotice of Results
29th Jul 20117:00 amRNSHalf year trading update
11th Jul 20117:00 amRNSFDA approval for Sensium
11th Jul 20117:00 amRNSJV established with CCE
5th May 20115:24 pmRNSResult of AGM
29th Mar 20117:00 amRNSFull year results
16th Mar 20113:16 pmRNSNotice of Results
16th Mar 20113:05 pmRNSHolding(s) in Company
3rd Mar 20114:34 pmRNSIssue of Equity
2nd Mar 20118:14 amRNS£1.8m Raised
10th Feb 20117:41 amRNSStrategic Investment
1st Feb 20117:00 amRNSTELRAN Launch
1st Feb 20117:00 amRNSYear End Trading Update
30th Nov 20107:00 amRNSXENIF processor in production
15th Sep 20107:00 amRNSInterim Results
24th Aug 20109:33 amRNSIssue of Equity
11th Aug 201011:52 amRNSNotice of Results
27th Jul 20107:00 amRNSLicense agreement
15th Jul 201010:19 amRNSIssue of Equity and Exercise of Options
30th Jun 20107:00 amRNSTrading Update
16th Jun 20108:49 amRNSAnnual Financial Report
26th May 20109:07 amRNSChange of Name
10th May 20102:52 pmRNSResult of AGM
30th Mar 20107:00 amRNSFinal Results
12th Mar 20109:00 amRNSQuanta takes strategic stake
11th Mar 20104:27 pmRNSDirector dealings
10th Mar 201011:26 amRNSNotice of Results
23rd Feb 20107:00 amRNSClinical Trial Update
1st Feb 20102:02 pmRNSExercise of Options - replacement
29th Jan 201012:33 pmRNSExercise of Options
22nd Dec 200911:19 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSHolding(s) in Company
17th Dec 20093:10 pmPRNResult of EGM
14th Dec 20093:34 pmPRNDirector/PDMR Shareholding
1st Dec 20097:00 amPRNProposed Placing and Update
9th Nov 20091:20 pmRNSNational Microelectronics Institute Award
2nd Nov 20097:00 amPRNSensium Digital Plaster European Trial
28th Sep 20097:00 amPRNHalf-yearly Report
22nd Sep 200912:16 pmRNSHolding(s) in Company
11th Sep 20097:00 amRNSCorrection re holding in company
10th Sep 20097:00 amRNSHolding(s) in Company
7th Aug 200912:01 pmRNSHolding(s) in Company
22nd Jul 200911:21 amPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.